Arena Investors LP - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 5 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Arena Investors LP ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q3 2023$130,900
-12.0%
85,0000.0%0.15%
+13.0%
Q2 2023$148,750
+78.6%
85,0000.0%0.13%
+104.7%
Q1 2023$83,300
-1.0%
85,0000.0%0.06%
-17.9%
Q4 2022$84,150
-99.5%
85,0000.0%0.08%
+875.0%
Q3 2022$16,235,000
+108133.3%
85,0000.0%0.01%
+14.3%
Q2 2022$15,000
-28.6%
85,0000.0%0.01%
-50.0%
Q1 2022$21,000
-99.9%
85,0000.0%0.01%
-54.8%
Q4 2021$29,750,00085,0000.03%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
BlueCrest Capital Management Ltd 1,235,000$222,0000.01%
Arena Investors LP 85,000$15,0000.01%
UBS Group AG 431$00.00%
AQR Arbitrage LLC 55,839$10,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Walleye Trading LLC 65,752$12,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 57,064$10,0000.00%
Walleye Capital LLC 89,623$16,0000.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders